Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hoogerland

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Molecular Metabolism|November 23, 2023
Hepatic ChREBP orchestrates intrahepatic carbohydrate metabolism to limit hepatic glucose 6-phosphate and glycogen accumulation in a mouse model for acute Glycogen Storage Disease type IbK A Krishnamurthy, M G S Rutten, J A Hoogerland, et al.
Hepatology (Baltimore, Md.)|February 22, 2020
Hepatic Carbohydrate Response Element Binding Protein Activation Limits Nonalcoholic Fatty Liver Disease Development in a Mouse Model for Glycogen Storage Disease Type 1aYu Lei, Joanne A Hoogerland, Vincent W Bloks, et al.
Cellular and Molecular Gastroenterology and Hepatology|December 14, 2020
Cholangiopathy and Biliary Fibrosis in Cyp2c70-Deficient Mice Are Fully Reversed by Ursodeoxycholic AcidJan Freark de Boer, Hilde D de Vries, Anna Palmiotti, et al.
Journal of Inherited Metabolic Disease|March 19, 2021
Impaired Very-Low-Density Lipoprotein catabolism links hypoglycemia to hypertriglyceridemia in Glycogen Storage Disease type IaJoanne A Hoogerland, Fabian Peeks, Brenda S Hijmans, et al.
Frontiers in Immunology|October 25, 2016
Supplementation with <i>Lactobacillus plantarum</i> WCFS1 Prevents Decline of Mucus Barrier in Colon of Accelerated Aging <i>Ercc1</i> MiceAdriaan A van Beek, Bruno Sovran, Floor Hugenholtz, et al.
Cancer & Metabolism|April 21, 2023
Normalization of hepatic ChREBP activity does not protect against liver disease progression in a mouse model for Glycogen Storage Disease type IaMartijn G S Rutten, Yu Lei, Joanne H Hoogerland, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Molecular Metabolism|November 23, 2023
Hepatic ChREBP orchestrates intrahepatic carbohydrate metabolism to limit hepatic glucose 6-phosphate and glycogen accumulation in a mouse model for acute Glycogen Storage Disease type IbK A Krishnamurthy, M G S Rutten, J A Hoogerland, et al.
Hepatology (Baltimore, Md.)|February 22, 2020
Hepatic Carbohydrate Response Element Binding Protein Activation Limits Nonalcoholic Fatty Liver Disease Development in a Mouse Model for Glycogen Storage Disease Type 1aYu Lei, Joanne A Hoogerland, Vincent W Bloks, et al.
Cellular and Molecular Gastroenterology and Hepatology|December 14, 2020
Cholangiopathy and Biliary Fibrosis in Cyp2c70-Deficient Mice Are Fully Reversed by Ursodeoxycholic AcidJan Freark de Boer, Hilde D de Vries, Anna Palmiotti, et al.
Journal of Inherited Metabolic Disease|March 19, 2021
Impaired Very-Low-Density Lipoprotein catabolism links hypoglycemia to hypertriglyceridemia in Glycogen Storage Disease type IaJoanne A Hoogerland, Fabian Peeks, Brenda S Hijmans, et al.
Frontiers in Immunology|October 25, 2016
Supplementation with <i>Lactobacillus plantarum</i> WCFS1 Prevents Decline of Mucus Barrier in Colon of Accelerated Aging <i>Ercc1</i> MiceAdriaan A van Beek, Bruno Sovran, Floor Hugenholtz, et al.
Cancer & Metabolism|April 21, 2023
Normalization of hepatic ChREBP activity does not protect against liver disease progression in a mouse model for Glycogen Storage Disease type IaMartijn G S Rutten, Yu Lei, Joanne H Hoogerland, et al.
Pageof 4